| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.22 | 0.003 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |